Burning Rock Biotech (BNR) Operating Margin (2018 - 2024)
Burning Rock Biotech (BNR) operating margin from Dec 31, 2018 to Dec 31, 2024. The current Burning Rock Biotech (BNR) operating margin is -69.32%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Annual Operating Margin change of Burning Rock Biotech (BNR)
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -69.32% | -44.34% |
| 2023 | -124.54% | -28.45% |
| 2022 | -174.07% | +10.91% |
| 2021 | -156.94% | +63.60% |
| 2020 | -95.93% | +116.54% |
| 2019 | -44.30% | -42.67% |
| 2018 | -77.27% | N/A |
Comparison Burning Rock Biotech (BNR) operating margin with competitors
Burning Rock Biotech (BNR) operating margin is -69.32%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 31.78% | -145.85% |
| SHC | Sotera Health Company | 28.16% | -140.62% |
| MTD | Mettler-Toledo International Inc | 26.00% | -137.51% |
| DHR | Danaher Corp | 22.58% | -132.57% |
| QGEN | Qiagen NV | 22.29% | -132.16% |
| MEDP | Medpace Holdings Inc | 20.03% | -128.90% |
| A | Agilent Technologies Inc | 19.63% | -128.32% |
| ILMN | Illumina Inc | 19.16% | -127.64% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | -124.42% |
| BLLN | Billiontoone Inc - Class A | 16.45% | -123.73% |
| VCYT | Veracyte Inc | 16.28% | -123.49% |
| DGX | Quest Diagnostics Inc | 13.78% | -119.88% |
| IQV | IQVIA Holdings Inc | 12.38% | -117.86% |
| CRL | Charles River Laboratories International Inc | 12.04% | -117.37% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -115.52% |
| RVTY | Revvity Inc | 10.67% | -115.39% |
| ICLR | Icon Plc | 5.37% | -107.75% |
| CDNA | Caredx Inc | 1.02% | -101.47% |